![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: C4orf33 |
Gene summary for C4ORF33 |
![]() |
Gene information | Species | Human | Gene symbol | C4orf33 | Gene ID | 132321 |
Gene name | chromosome 4 open reading frame 33 | |
Gene Alias | C4orf33 | |
Cytomap | 4q28.2 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q8N1A6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
132321 | C4orf33 | LZE24T | Human | Esophagus | ESCC | 1.15e-06 | 1.22e-01 | 0.0596 |
132321 | C4orf33 | P1T-E | Human | Esophagus | ESCC | 9.83e-06 | 1.60e-01 | 0.0875 |
132321 | C4orf33 | P2T-E | Human | Esophagus | ESCC | 2.97e-12 | 1.47e-01 | 0.1177 |
132321 | C4orf33 | P4T-E | Human | Esophagus | ESCC | 7.48e-06 | 8.75e-02 | 0.1323 |
132321 | C4orf33 | P5T-E | Human | Esophagus | ESCC | 3.50e-02 | 4.13e-02 | 0.1327 |
132321 | C4orf33 | P11T-E | Human | Esophagus | ESCC | 3.13e-04 | 1.00e-01 | 0.1426 |
132321 | C4orf33 | P15T-E | Human | Esophagus | ESCC | 6.43e-07 | 3.69e-02 | 0.1149 |
132321 | C4orf33 | P17T-E | Human | Esophagus | ESCC | 1.86e-02 | 7.86e-02 | 0.1278 |
132321 | C4orf33 | P20T-E | Human | Esophagus | ESCC | 6.88e-09 | 9.05e-02 | 0.1124 |
132321 | C4orf33 | P21T-E | Human | Esophagus | ESCC | 8.17e-12 | 1.80e-01 | 0.1617 |
132321 | C4orf33 | P22T-E | Human | Esophagus | ESCC | 9.51e-03 | 8.80e-04 | 0.1236 |
132321 | C4orf33 | P23T-E | Human | Esophagus | ESCC | 2.74e-02 | 1.16e-01 | 0.108 |
132321 | C4orf33 | P24T-E | Human | Esophagus | ESCC | 1.15e-07 | 1.80e-01 | 0.1287 |
132321 | C4orf33 | P26T-E | Human | Esophagus | ESCC | 5.55e-13 | 1.85e-01 | 0.1276 |
132321 | C4orf33 | P27T-E | Human | Esophagus | ESCC | 6.22e-04 | 3.66e-02 | 0.1055 |
132321 | C4orf33 | P28T-E | Human | Esophagus | ESCC | 9.05e-04 | 6.58e-02 | 0.1149 |
132321 | C4orf33 | P31T-E | Human | Esophagus | ESCC | 1.16e-09 | 1.03e-01 | 0.1251 |
132321 | C4orf33 | P32T-E | Human | Esophagus | ESCC | 2.69e-12 | 1.96e-01 | 0.1666 |
132321 | C4orf33 | P36T-E | Human | Esophagus | ESCC | 1.18e-05 | 1.06e-01 | 0.1187 |
132321 | C4orf33 | P37T-E | Human | Esophagus | ESCC | 9.99e-07 | 2.49e-02 | 0.1371 |
Page: 1 2 3 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
C4orf33 | SNV | Missense_Mutation | c.226N>C | p.Glu76Gln | p.E76Q | Q8N1A6 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A8-A08R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
C4orf33 | SNV | Missense_Mutation | c.83G>A | p.Arg28Lys | p.R28K | Q8N1A6 | protein_coding | tolerated(0.62) | benign(0) | TCGA-BH-A2L8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | CR | |
C4orf33 | SNV | Missense_Mutation | c.83G>A | p.Arg28Lys | p.R28K | Q8N1A6 | protein_coding | tolerated(0.62) | benign(0) | TCGA-B5-A0K8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD | |
C4orf33 | SNV | Missense_Mutation | novel | c.440A>G | p.Glu147Gly | p.E147G | Q8N1A6 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
C4orf33 | SNV | Missense_Mutation | c.346G>T | p.Gly116Cys | p.G116C | Q8N1A6 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BS-A0TE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
C4orf33 | SNV | Missense_Mutation | novel | c.411N>G | p.Ile137Met | p.I137M | Q8N1A6 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
C4orf33 | SNV | Missense_Mutation | c.367N>T | p.Ser123Cys | p.S123C | Q8N1A6 | protein_coding | tolerated(0.1) | benign(0.01) | TCGA-50-6594-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
C4orf33 | SNV | Missense_Mutation | novel | c.290N>T | p.Trp97Leu | p.W97L | Q8N1A6 | protein_coding | tolerated(0.16) | benign(0.173) | TCGA-85-A53L-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
C4orf33 | SNV | Missense_Mutation | c.178N>A | p.Glu60Lys | p.E60K | Q8N1A6 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-CV-6952-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
C4orf33 | SNV | Missense_Mutation | novel | c.96N>A | p.Met32Ile | p.M32I | Q8N1A6 | protein_coding | tolerated(0.16) | benign(0.038) | TCGA-CV-7095-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |